Table 2 Demographics and asymmetrical dimethyl arginine (ADMA) levels by group
Parameter | Survivors | Non-survivors | p |
|---|---|---|---|
Total patients | 33 (70) | 14 (30) | Â |
Male sex | 17 (52) | 9 (64) | ns |
SOFA score, day 1 | 7 (4–10) | 9 (8.75–12.5) | 0.02 |
SOFA score, day 7 | 4 (2.75–7.25) | 10.5 (8.5–11.75) | 0.006 |
SAPS2 score | 39 (30.5–51.5) | 47.5 (39.5–60.75) | ns |
Lactate, day 1 | 2.1 (1.5–5) | 3.6 (2.25–5.75) | ns |
Lactate, day 7 | 1.5 (1–1.9) | 2 (1.1–4) | ns |
Vasoactive agents, day 1 | 18 (55) | 13 (93) | 0.01 |
Vasoactive agents, day 7 | 5 (15) | 5 (63) | 0.005 |
ADMA, day 1 | 0.88 (0.52–1.09) | 0.91 (0.64–1.23) | ns |
ADMA, day 7 | 1.05 (0.66–1.21) | 1.24 (0.77–1.53) | ns |
pH, day 1 | 7.31 (7.26–7.38) | 7.33 (7.27–7.37) | ns |
pH, day 7 | 7.44 (7.40–7.45) | 7.32 (7.24–7.40) | 0.002 |
WCC, day 1 | 18 (10.7–23) | 9.1 (2.3–17.8) | ns |
WCC, day 7 | 11.6 (8.6–17.4) | 13.9 (8.5–19.3) | ns |
Base excess, day 1 | -2.9 (-6.45 to 1.75) | -4.1 (-9.3 to 1.75) | ns |
Base excess, day 7 | 2.9 (1.1–5.6) | 0.1 (-3 to 1.33) | 0.009 |
IL-6, day 1 | 277 (107–499) | 782 (566–1,060) | 0.001 |
IL-6, day 7 | 22 (0–651) | 130 (68–425) | ns |